Sandi Kwee to Positron-Emission Tomography
This is a "connection" page, showing publications Sandi Kwee has written about Positron-Emission Tomography.
Connection Strength
3.454
-
Kwee SA, Lim J, Watanabe A, Kromer-Baker K, Coel MN. Prognosis Related to Metastatic Burden Measured by ?8F-Fluorocholine PET/CT in Castration-Resistant Prostate Cancer. J Nucl Med. 2014 Jun; 55(6):905-10.
Score: 0.459
-
Kwee SA, Coel MN, Lim J. Detection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging. Ann Nucl Med. 2012 Jul; 26(6):501-7.
Score: 0.402
-
Kwee S, Song MA, Cheng I, Loo L, Tiirikainen M. Measurement of circulating cell-free DNA in relation to 18F-fluorocholine PET/CT imaging in chemotherapy-treated advanced prostate cancer. Clin Transl Sci. 2012 Feb; 5(1):65-70.
Score: 0.397
-
Kwee S, Ernst T. Total choline at 1H-MRS and [18F]-fluoromethylcholine uptake at PET. Mol Imaging Biol. 2010 Aug; 12(4):424-5; author reply 426.
Score: 0.356
-
Kwee SA, Coel MN, Ly BH, Lim J. (18)F-Choline PET/CT imaging of RECIST measurable lesions in hormone refractory prostate cancer. Ann Nucl Med. 2009 Aug; 23(6):541-8.
Score: 0.329
-
Kwee SA, DeGrado T. Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels. Eur J Nucl Med Mol Imaging. 2008 Aug; 35(8):1567-9; author reply 1570.
Score: 0.310
-
Kwee SA, Thibault GP, Stack RS, Coel MN, Furusato B, Sesterhenn IA. Use of step-section histopathology to evaluate 18F-fluorocholine PET sextant localization of prostate cancer. Mol Imaging. 2008 Jan-Feb; 7(1):12-20.
Score: 0.298
-
Kwee SA, Wei H, Sesterhenn I, Yun D, Coel MN. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. J Nucl Med. 2006 Feb; 47(2):262-9.
Score: 0.261
-
Kwee SA, Coel MN, Lim J, Ko JP. Prostate cancer localization with 18fluorine fluorocholine positron emission tomography. J Urol. 2005 Jan; 173(1):252-5.
Score: 0.242
-
Kuang Y, Wu L, Hirata E, Miyazaki K, Sato M, Kwee SA. Volumetric modulated arc therapy planning for primary prostate cancer with selective intraprostatic boost determined by 18F-choline PET/CT. Int J Radiat Oncol Biol Phys. 2015 Apr 01; 91(5):1017-25.
Score: 0.123
-
Lan BY, Kwee SA, Wong LL. Positron emission tomography in hepatobiliary and pancreatic malignancies: a review. Am J Surg. 2012 Aug; 204(2):232-41.
Score: 0.100
-
Kwee SA, Coel MN. Detection of synchronous primary breast and prostate cancer by F-18 fluorocholine PET/CT. Clin Nucl Med. 2010 Feb; 35(2):128-9.
Score: 0.086
-
Kwee SA, DeGrado TR, Talbot JN, Gutman F, Coel MN. Cancer imaging with fluorine-18-labeled choline derivatives. Semin Nucl Med. 2007 Nov; 37(6):420-8.
Score: 0.074
-
DeGrado TR, Kwee SA, Coel MN, Coleman RE. The impact of urinary excretion of (18)F-labeled choline analogs. J Nucl Med. 2007 Jul; 48(7):1225.
Score: 0.018